Ortho Evra Birth Control Patch Lawyers at Anapol Schwartz | Philadelphia Pennsylvania Attorneys at Law
  Do I have an Ortho Evra Birth Control Patch case? ... Contact us for a free consultation with one of our Lawyers

About Ortho Evra

Benefits of Retaining Anapol Schwartz

Do you have an Ortho Evra Birth Control Patch case?

Web Resources

Ortho Evra Blog

 

Ortho Evra FDA Black Box Warning

Contact us for a free legal consultation about your Ortho Evra Birth Control Patch Lawsuit

On November 10, 2005, the Food and Drug Administration (FDA) updated the Ortho Evra contraceptive birth control patch labeling to warn women that they are exposed to higher levels of estrogen than from taking birth control pills.

The FDA advised women to talk to their doctor or healthcare provider about whether the birth control patch is the right method of birth control for them and for healthcare providers to warn against the potential risks of increased estrogen exposure.

The warning further stated: In general, increased estrogen exposure may increase the risk of blood clots. The addition of this new warning is a result of FDA's and the manufacturer's analysis directly comparing the levels for estrogen and progestin hormones in users of Ortho Evra with those in a typical birth control pill. However, it is not known whether women using Ortho Evra are at a greater risk of experiencing these serious adverse events.

The new bolded warning specifically states that women who use Ortho Evra are exposed to about 60 percent more total estrogen in their blood than if they were taking a typical birth control pill containing 35 micrograms of estrogen. However, the maximal blood level of estrogen (peak blood levels) is about 25 percent lower with Ortho Evra than with typical birth control pills. While the estrogen level with the patch remains constant for one week until the patch is removed, the peak blood levels with a daily birth control pill rapidly declines to levels that are lower than on the Ortho Evra.

FDA is continuing to monitor safety reports for the Ortho Evra patch. The manufacturer, Ortho McNeil Pharmaceuticals is conducting additional studies to compare the risk of developing serious blood clots in women using Ortho Evra to the risk in women using typical birth control pills that contain 35 micrograms of estrogen.

Do you have a birth control patch lawsuit?

 

 

Do you need an Ortho Evra Birth Control Patch

Lawyer by your side?


PERSONAL INFORMATION

Title:
First Name: *
Last Name: *
E-mail Address: *
Address:
City:
State:
Zipcode:
Phone: * () - ext.
Date of Birth:


ORTHO EVRA LAWSUIT INFORMATION

Are you a smoker or non-smoker?
Please describe your problems from Ortho Evra:
Please indicate which condition(s) the doctor diagnosed: (check all that apply)
Blood Clot
Heart Attack
Stroke
Pulmonary Embolism (PE)
Myocardial Infaraction (MI)
Deep Vein Thrombosis (DVT)
Cerebrovascular Accidents (CVA)
Other
If you have any other injury, please describe:
Date of Diagnosis


BIRTH CONTROL INFORMATION


When did you use the Ortho Evra Birth Control Patch?
Start Date
End Date
What other types of birth control have you used in the past 3 years?

Copyright © 2004- - Anapol Schwartz - Pennsylvania Ortho Evra Birth Control Patch Case Attorneys - New Jersey Ortho Evra Birth Control Patch Lawyers - Ortho Evra Birth Control Patch Class Action Law Firm. All rights reserved.

Ortho Evra Birth Control Patch Attorney Disclaimer: This website is dedicated to providing public information regarding Ortho Evra Birth Control Patch and other legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Pennsylvania Ortho Evra Birth Control Patch Case lawyer or Philadelphia Ortho Evra Birth Control Patch Case attorney at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey, Pennsylvania, and West Virginia.